The latest announcement is out from Hydration Pharmaceuticals Co. Ltd. ( (AU:HPC) ).
Hydration Pharmaceuticals Co. Ltd. has announced a non-renounceable pro rata entitlement offer to raise approximately $610,000 through the issuance of new shares at $0.01 each. This capital raising effort, managed by Evolution Capital Pty Ltd., is aimed at strengthening the company’s financial position, though it is not underwritten and is considered a highly speculative investment. The offer is not extended to shareholders outside of Australia and New Zealand, reflecting the company’s current market focus.
More about Hydration Pharmaceuticals Co. Ltd.
Hydration Pharmaceuticals Co. Ltd., also known as Hydralyte USA, operates in the pharmaceutical industry, focusing on hydration products. The company is involved in the development and distribution of hydration solutions, targeting markets primarily in Australia and New Zealand.
YTD Price Performance: -50.0%
Average Trading Volume: 418,598
Technical Sentiment Signal: Buy
Find detailed analytics on HPC stock on TipRanks’ Stock Analysis page.